News
April 30, 2021
Expanded the functions of the AI review tool “KIBIT Automator” which is a key to FRONTEO’s portfolio transformation, enabling one-stop handling of eDiscovery process from pre-processing to document review.
September 9, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
March 25, 2020
May 13, 2024
FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.
January 24, 2024
Explanation of points to keep in mind when Japanese companies negotiate with U.S. government agencies, crisis management, and the use of AI
August 25, 2023
FRONTEO was thrilled to sponsor and attend ILTACON 2023, which was held this year in Orlando, FL, from August 20th through August 24th.
April 15, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
February 15, 2017
October 5, 2023
NEW YORK, October 5, 2023 – FRONTEO (TSE: 2158) is pleased to announce that Shiho Tanaka, Global Sales Executive, LegalTech AI Division, FRONTEO, Inc and Senior Vice President, Data Science & Technology Department, FRONTEO USA, will be speaking at the 5th White Collar Crime Workshop 2023, organized by Daisuke Fukamizu of Nagashima Ohno & Tsunematsu, LLP.
January 30, 2017
January 28, 2025
Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.
November 12, 2024
FRONTEO, Inc. (Head Office: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereafter "FRONTEO") is pleased to announce that an agreement has been reached to provide Daiichi Sankyo Co., Ltd. (Head Office: Chuo-ku, Tokyo; President and COO: Hiroyuki Okuzawa; hereafter "Daiichi Sankyo") with analysis services using Drug Discovery AI Factory (hereafter "DDAIF")* to analyze text information from toxicity study databases and reports.
February 6, 2024
Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
January 12, 2024
FRONTEO is a proud sponsor of Legalweek 2024 at the New York Hilton Midtown – January 29th – February 1st. Come join your peers in the legal profession at this annual gathering.
June 7, 2023
FRONTEO is pleased to share the exciting news of its recent affiliation with ACEDS (Association of Certified E-Discovery Specialists)
January 20, 2023
Earlier in 2022, FRONTEO was pleased to announce the release of its proprietary e-Discovery hosting platform called KIBIT Automator Review or KAMR.